Fennec Pharmaceuticals Inc.
US ˙ NasdaqCM ˙ CA31447P1009

SecurityFENC / Fennec Pharmaceuticals Inc.
InstitutionSimplex Trading, Llc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Simplex Trading, Llc ownership in FENC / Fennec Pharmaceuticals Inc.

On February 11, 2026 - Simplex Trading, Llc filed a 13F-HR form disclosing ownership of 0 shares of Fennec Pharmaceuticals Inc. (US:FENC) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 12, 2025 disclosing 21,270 shares of Fennec Pharmaceuticals Inc.. The current value of the position is $0 USD.

Simplex Trading, Llc has a history of taking positions in derivatives of the underlying security (FENC) in the form of stock options. The firm currently holds call options representing 100 of underlying shares valued at $615 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

FENC / Fennec Pharmaceuticals Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F FENNEC PHARMACEUTICALS COM 31447P100 0 -21,270 -100.00 0 0.0000
2025-11-12 2025-09-30 13F FENNEC PHARMACEUTICALS COM 31447P100 21,270 -1,440 -6.34 0 0.0001
2025-08-05 2025-06-30 13F FENNEC PHARMACEUTICALS COM 31447P100 22,710 22,458 8,911.90 0 0.0001
2025-05-12 2025-03-31 13F FENNEC PHARMACEUTICALS COM 31447P100 252 252 0 0.0000
2025-02-11 2024-12-31 13F FENNEC PHARMACEUTICALS COM 31447P100 0 -21 -100.00 0 0.0000
2024-11-08 2024-09-30 13F FENNEC PHARMACEUTICALS COM 31447P100 21 21 0 0.0000
2024-04-25 2024-03-31 13F FENNEC PHARMACEUTICALS COM 31447P100 0 -12 -100.00 0 0.0000
2024-02-02 2023-12-31 13F FENNEC PHARMACEUTICALS COM 31447P100 12 12 0 0.0000
2023-04-27 2023-03-31 13F FENNEC PHARMACEUTICALS COM 31447P100 0 -2,921 -100.00 0 0.0000
2023-02-02 2022-12-31 13F FENNEC PHARMACEUTICALS COM 31447P100 2,921 2,921 0 0.0000
2022-11-04 2022-09-30 13F FENNEC PHARMACEUTICALS COM 31447P100 0 -2,177 -100.00 0 -100.00
2022-08-03 2022-06-30 13F FENNEC PHARMACEUTICALS COM 31447P100 2,177 2,177 12 0.0000
2022-05-02 2022-03-31 13F FENNEC PHARMACEUTICALS COM 31447P100 0 -899 -100.00 0 -100.00
2022-02-23 2021-12-31 13F/A-1 FENNEC PHARMACEUTICALS COM 31447P100 899 658 273.03 3 200.00 0.0000
2022-02-04 2021-12-31 13F FENNEC PHARMACEUTICALS COM 31447P100 241 0 1 0.0000
2021-10-28 2021-09-30 13F FENNEC PHARMACEUTICALS COM 31447P100 241 0 0.00 1 0.00 0.0000
2021-08-12 2021-06-30 13F FENNEC PHARMACEUTICALS COM 31447P100 241 -845 -77.81 1 -83.33 0.0000
2021-04-26 2021-03-31 13F FENNEC PHARMACEUTICALS COM 31447P100 1,086 -874 -44.59 6 -57.14 0.0000
2021-02-02 2020-12-31 13F FENNEC PHARMACEUTICALS COM 31447P100 1,960 1,853 1,731.78 14 133.33 0.0000
2020-10-14 2020-09-30 13F FENNEC PHARMACEUTICALS COM 31447P100 107 -1,253 -92.13 0 -100.00
2020-07-13 2020-06-30 13F FENNEC PHARMACEUTICALS COM 31447P100 1,360 1,360 1,171.03 11 0.0000
2020-02-05 2019-12-31 13F FENNEC PHARMACEUTICALS COM 31447P100 0 -100 -100.00 0 -100.00 0.0000
2019-10-15 2019-09-30 13F FENNEC PHARMACEUTICALS COM 31447P100 100 100 0 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F FENNEC PHARMACEUTICALS CALL Call 100 0.00 1 n/a n/a n/a
2026-02-11 2025-12-31 13F FENNEC PHARMACEUTICALS CALL Call 100 -90.00 1 n/a n/a n/a
2025-11-12 2025-09-30 13F FENNEC PHARMACEUTICALS CALL Call 1,000 -23.08 0 n/a n/a n/a
2025-08-05 2025-06-30 13F FENNEC PHARMACEUTICALS CALL Call 1,300 0 n/a n/a n/a
2025-02-11 2024-12-31 13F FENNEC PHARMACEUTICALS CALL Call 0 -100.00 0 n/a n/a n/a
2024-11-08 2024-09-30 13F FENNEC PHARMACEUTICALS CALL Call 4,200 1,300.00 0 n/a n/a n/a
2024-07-25 2024-06-30 13F FENNEC PHARMACEUTICALS CALL Call 300 -72.73 0 n/a n/a n/a
2024-04-25 2024-03-31 13F FENNEC PHARMACEUTICALS CALL Call 1,100 450.00 0 n/a n/a n/a
2024-02-02 2023-12-31 13F FENNEC PHARMACEUTICALS CALL Call 200 -98.94 0 n/a n/a n/a
2023-11-01 2023-09-30 13F FENNEC PHARMACEUTICALS CALL Call 18,900 37.96 0 n/a n/a n/a
2023-08-04 2023-06-30 13F FENNEC PHARMACEUTICALS CALL Call 13,700 -30.10 0 n/a n/a n/a
2023-04-27 2023-03-31 13F FENNEC PHARMACEUTICALS CALL Call 19,600 66.10 0 n/a n/a n/a
2023-02-02 2022-12-31 13F FENNEC PHARMACEUTICALS CALL Call 11,800 8.26 0 -100.00 n/a n/a n/a
2022-11-04 2022-09-30 13F FENNEC PHARMACEUTICALS CALL Call 10,900 3,533.33 88 8,700.00 n/a n/a n/a
2022-08-03 2022-06-30 13F FENNEC PHARMACEUTICALS CALL Call 300 -81.25 1 -87.50 n/a n/a n/a
2022-05-02 2022-03-31 13F FENNEC PHARMACEUTICALS CALL Call 1,600 -73.33 8 -69.23 n/a n/a n/a
2022-02-23 2021-12-31 13F/A FENNEC PHARMACEUTICALS CALL Call 6,000 5,900.00 26 n/a n/a n/a
2022-02-04 2021-12-31 13F FENNEC PHARMACEUTICALS CALL Call 100 0 n/a n/a n/a
2021-10-28 2021-09-30 13F FENNEC PHARMACEUTICALS CALL Call 100 0.00 0 n/a n/a n/a
2021-08-12 2021-06-30 13F FENNEC PHARMACEUTICALS CALL Call 100 0 n/a n/a n/a
2021-04-26 2021-03-31 13F FENNEC PHARMACEUTICALS CALL Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-02 2020-12-31 13F FENNEC PHARMACEUTICALS CALL Call 14 10 n/a n/a n/a
2020-10-14 2020-09-30 13F FENNEC PHARMACEUTICALS CALL Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-07-13 2020-06-30 13F FENNEC PHARMACEUTICALS CALL Call 86 -3.37 71 36.54 n/a n/a n/a
2020-04-29 2020-03-31 13F FENNEC PHARMACEUTICALS CALL Call 89 52 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-08-05 2025-06-30 13F FENNEC PHARMACEUTICALS PUT Put 0 -100.00 0 n/a n/a n/a
2025-05-12 2025-03-31 13F FENNEC PHARMACEUTICALS PUT Put 300 0 n/a n/a n/a
2024-02-02 2023-12-31 13F FENNEC PHARMACEUTICALS PUT Put 0 -100.00 0 n/a n/a n/a
2023-11-01 2023-09-30 13F FENNEC PHARMACEUTICALS PUT Put 4,000 33.33 0 n/a n/a n/a
2023-08-04 2023-06-30 13F FENNEC PHARMACEUTICALS PUT Put 3,000 400.00 0 n/a n/a n/a
2023-04-27 2023-03-31 13F FENNEC PHARMACEUTICALS PUT Put 600 0.00 0 n/a n/a n/a
2023-02-02 2022-12-31 13F FENNEC PHARMACEUTICALS PUT Put 600 -99.32 0 -100.00 n/a n/a n/a
2022-11-04 2022-09-30 13F FENNEC PHARMACEUTICALS PUT Put 87,900 1,231.82 711 1,821.62 n/a n/a n/a
2022-08-03 2022-06-30 13F FENNEC PHARMACEUTICALS PUT Put 6,600 13.79 37 15.63 n/a n/a n/a
2022-05-02 2022-03-31 13F FENNEC PHARMACEUTICALS PUT Put 5,800 141.67 32 220.00 n/a n/a n/a
2022-02-23 2021-12-31 13F/A FENNEC PHARMACEUTICALS PUT Put 2,400 2,300.00 10 n/a n/a n/a
2022-02-04 2021-12-31 13F FENNEC PHARMACEUTICALS PUT Put 100 0 n/a n/a n/a
2021-10-28 2021-09-30 13F FENNEC PHARMACEUTICALS PUT Put 100 0.00 0 n/a n/a n/a
2021-08-12 2021-06-30 13F FENNEC PHARMACEUTICALS PUT Put 100 0 n/a n/a n/a
2020-10-14 2020-09-30 13F FENNEC PHARMACEUTICALS PUT Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-07-13 2020-06-30 13F FENNEC PHARMACEUTICALS PUT Put 4 3 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.